Appetite Loss and Anorexia of Aging in Clinical Care: An ICFSR Task Force Report - 21/11/24
, M. Cesari 3, J.E. Morley 4, S. Roberts 5, F. Landi 6, T. Cederholm 7, Y. Rolland 1, 2, B. Vellas 1, 2, R. Fielding 8
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Appetite loss/anorexia of aging is a highly prevalent and burdensome geriatric syndrome that strongly impairs the quality of life of older adults. Loss of appetite is associated with several clinical conditions, including comorbidities and other geriatric syndromes, such as frailty. Despite its importance, appetite loss has been under-evaluated and, consequently, under-diagnosed and under-treated in routine clinical care. The International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force met virtually on September 27th 2021 to debate issues related to appetite loss/anorexia of aging. In particular, topics related to the implementation and management of appetite loss in at-risk older adult populations, energy balance during aging, and the design of future clinical trials on this topic were discussed. Future actions in this field should focus on the systematic assessment of appetite in the care pathway of older people, such as the Integrated Care for Older People (ICOPE) program recommended by the World Health Organization. Moreover, clinical care should move from the assessment to the treatment of appetite loss/anorexia. Researchers continue to pursue their efforts to find out effective pharmacologic and non-pharmacologic interventions with a favorable risk/benefit ratio.
Le texte complet de cet article est disponible en PDF.Key words : Anorexia, nutritional status, older adults, frailty, intrinsic capacity
Plan
| Task force members: Sandrine Andrieu (Toulouse, France); Domenico Azzolino (Milano, Italy); Nuria Barcons (Barcelona, Spain); Ann Beliën (Heusden-Zolder, Belgium); Roberto Bernabei (Roma, Italy); Shalender Bhasin (Boston, USA); Roberto Calle (New York, USA); Maria Camprubi Robles (Columbus, USA); Bill Chan (Beijing, China); Liang-Kung Chen (Taipei City, Taiwan); Carla Delannoy (Vevey, Switzerland); Waly Dioh (Paris, France); John Groarke (New York, USA); Darren Hwee (South San Francisco, USA); Valérie Legrand (Nanterre, France); Yvette Luiking (Utrecht, The Netherlands); Jean Mariani (Paris, France); Anthony Oliva (Miami, USA); Marco Pahor (Gainesville, USA); Caterina Parenti (Verone, Italy); Suzette Pereira (Columbus, USA); Erin Quann (Vevey, Switzerland); Daniel Rooks (Cambridge, USA); Michelle Rossulek (New York, USA); Ricardo Rueda (Columbus, USA); Jorge Ruiz (Miami, USA); Lisa Tarasenko (New York, USA); Cendrine Tourette (Paris, France); Rob Van Maanen (Paris, France) |
Vol 11 - N° 2
P. 129-134 - avril 2022 Retour au numéro
Article précédent
- The Management of Frailty: Barking Up the Wrong Tree
- Matteo Cesari, M. Canevelli, R. Calvani, I. Aprahamian, M. Inzitari, E. Marzetti
- Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force
- Matteo Cesari, R. Bernabei, B. Vellas, R.A. Fielding, D. Rooks, D. Azzolino, J. Mariani, A.A. Oliva, S. Bhasin, Y. Rolland, ICFSR Task Force members
Bienvenue sur EM-consulte, la référence des professionnels de santé.